Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma. uri icon

authors

  • Richard J Lin, MD, PhD
  • Dahi, Parastoo B
  • Giralt, Sergio A
  • Hamlin, Paul A
  • Mead, Elena
  • Noy, Arela
  • Palomba, M Lia
  • Santomasso, Bianca D
  • Sauter, Craig S
  • Scordo, Michael
  • Shah, Gunjan L
  • Lobaugh, Stephanie M
  • Korc-Grodzicki, Beatriz
  • Kim, Soo Jung
  • Silverberg, Mari Lynne
  • Brooklyn, Chelsea A
  • Devlin, Sean M
  • Perales, Miguel-Angel
  • Pennisi, Martina
  • Chan, Hei Ton
  • Batlevi, Yakup
  • Ruiz, Josel D
  • Elko, Theresa A
  • Maloy, Molly A
  • Batlevi, Connie L

publication date

  • January 1, 2021